Cagrilintide

Cagrilintide is a long-acting amylin analogue that acts through amylin receptors via complementary mechanisms to GLP-1 agonists. Research focuses on gastric motility modulation, glucagon secretion regulation, and caloric intake signaling. Often co-administered with semaglutide in preclinical combination studies. Supplied as lyophilized powder for research use only.

Research Use Only. All products sold on this website are strictly for laboratory research, in-vitro testing, and analytical purposes only. Products are not intended for human consumption, diagnostic, therapeutic, or any medical applications. Not evaluated or approved by the FDA.